March 30, 2016 – – Hinsdale, Illinois based company, The Business Technologist, has announced a new suite of services. With these services, the company aims to help clients avoid costly technology and marketing mistakes by keeping them on track both in the use of technology and in choosing marketing strategies and tactics. The company is a spin-off from Ask InfoMedia, which has provided help to businesses in the Chicagoland Area for more than 10 years.

Company owner Jeff Ellis states, “We branched out and founded The Business Technologist to expand our capabilities in helping clients.” Ellis says that over the years, the company has been helping clients to meet and exceed their expectations, but that they were forced to turn down clients because they did not have the capacity to help everyone who needed it.

“Nearly all of our clients were making poor choices, because they lacked some very crucial facts,” explains Jeff Ellis. He states that the company’s clients could not effectively bring awareness of their businesses because they had no idea where to begin and unfortunately, Ask InfoMedia did not have the manpower to help everyone who needed it. He declares, “Now, we have the means of helping a much larger number of clients, and helping them to navigate and stay on track.”

Jeff Ellis says that in founding the new business, they can help thousands of additional clients with similar problems and challenges that hinder their business growth. He has a degree on Bio-Electrical Engineering, and has been an entrepreneur for more than 15 years. Before founding his own company, he held multiple sales positions and co-authored the eBook “How to Get the Interviews You Want.”

Upon his success in selling his eBook, after he learned effective ways of marketing it, he co-founded Ask InfoMedia and later on his most recent business, The Business Technologist.com. He states that his goal with both companies is to help other businesses and entrepreneurs to enjoy the same success as he has gained, while utilizing the most effective marketing strategies and tactics available.

Those interested in learning more about the company and the kind of marketing services that they provide can visit them on their official website at https://www.thebusinesstechnologist.com.

###

Contact The Business Technologist:

Jeffrey Ellis
(855) 636-8220
support@BTGuru.com
22 Blaine Street
Hinsdale, IL 60521

ReleaseID: 60008927

March 30, 2016 – – BulldogLawyers.com has released a guideline for anyone who has been injured on the job in Pennsylvania and has questions regarding the process of filing a workers’ compensation claim.

Every year, thousands of hard working professionals are seriously injured at work. Some of the most common injuries sustained on the job include burns, amputations, toxic exposure, bone, muscle, and joint damage, back and spinal injuries, animal bites, electrocution, brain injuries, and overexertion. These injuries typically require extensive medical care, hospitalization, and physical therapy. More often than not, the injured employee is unable to return to work, either temporarily or permanently.

Injured workers are entitled to file a workers’ compensation claim so that the medical expenses and a fraction of lost wages are covered. Unfortunately, the worker’s compensation system is far from perfect and even something as simple as an incorrectly filled out form can result in a denial.

Working with a workers’ compensation lawyer can make this process much less stressful and can ensure that an employee receives the benefits they need as soon as possible. For those who have already received a denial, an attorney can help them determine the reason for the denial, file an appeal, speak to the insurance company, and represent them at any hearings.

The guideline that The Bulldog Lawyers have published addresses frequently asked questions that the lawyers are asked by clients, including how to file, what types of medical expenses are covered, and how long an injured employee can collect benefits for.

The firm has assisted Pennsylvania workers who have been injured on the job for more than 40 years and are committed to providing their clients with excellent legal assistance. For more information, contact their office at (800) 681-7000.

###

Contact BulldogLawyers.com:

Jay Shor
(800) 681-7000
shor.and.levin@gmail.com
261 Old York Road, Suite 200
Jenkintown, PA 19046

ReleaseID: 60008991

March 30, 2016 – – BloodThinnerHelp.com reports on a commonly cited adverse side effect that plaintiffs in Xarelto lawsuits allege is a direct result of the blood-thinning drug. According to many patients who have used Xarelto and filed lawsuits against its manufacturers, Johnson & Johnson and Bayer AG, pulmonary embolism, or a blood clot in the lung, is a common life-threatening side effect along with several others.

Xarelto was first approved by the FDA in 2011 to treat and prevent several health problems having to do with acute coronary syndrome and other issues including preventing the recurrence of blood clots and deep vein thrombosis in patients undergoing knee and hip replacements. Since its approval, the companies have faced thousands of federally-filed lawsuits alleging that patients were not adequately warned about the possible side effects including internal bleeding, brain hemorrhages, rectal bleeding, epidural hematoma, pulmonary embolism, heart attack and stroke. According to a report released in 2013, the most common of those side effects is pulmonary embolism, affecting 386 of the 2,100 of adverse reports concerning Xarelto.

Pulmonary embolism is the sudden blockage of a major vessel in the lung. The blockage is usually caused by a blood clot which, if big enough, can cause major damage to the lung or stop blood flow, becoming deadly. Having blood clots in deep veins can lead to pulmonary embolism, a condition from which 300,000 people suffer each year along with deep vein thrombosis. Symptoms of pulmonary embolism include sudden shortness of breath, chest pain that is worse when you cough or take a deep breath and a cough that brings up pink foamy mucus.

As more cases are expected to be brought to court concerning the alleged side effects, Attorney Joseph Osborne is working to help ensure that anyone who has taken Xarelto and has also experienced negative side effects that they attribute to the drug will be given the opportunity to thoroughly investigate their legal rights. These people could be entitled to significant compensation. Osborne is offering complimentary legal consultations to affected parties at this time.

To request further information on Xarelto, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008961

March 30, 2016 – – ZofranLegal.com reports on the concerning results of recent foreign animal studies which appear to support the claims of current plaintiffs involved in Zofran lawsuits by connecting exposure to the drug to a heightened risk of birth defect development in unborn animals. Only months after over 200 Zofran lawsuits were transferred and consolidated to a Boston federal court by the U.S. JPML, Zofran manufacturer and defendant GlaxoSmithKline requested that all cases be dismissed with a contentious motion filed on December 11th of 2015.

In time, the motion was dismissed by the Honorable Judge F. Dennis Saylor IV, but it will be possible for GSK to request this motion again in the future. Plaintiffs responded to GSK’s motion for dismissal by stating that there was, “reason to believe that GSK had important evidence about the defects alleged […], and the link to Zofran.” To help support this argument, plaintiffs pulled details from the results of multiple “animal teratogenicity studies” which GSK had reportedly conducted overseas in Japan. The study results seem to connect exposure to the drug to an increased risk for the development of congenital heart defects among animal’s unborn babies, which bears a striking resemblance to allegations made by the plaintiffs who indicate that their children have been born with defects after being exposed to the drug while in utero.

Plaintiffs state that the studies highlighted pregnant animals who were exposed to Zofran and who subsequently gave birth to offspring which had developed ventricular septal defects. They also claim that the studies took place after the drug had gained FDA approval for U.S. sales. Interestingly enough, however, Zofran was never approved by the FDA to treat pregnant women or tested for safety on this consumer group and their unborn babies. Instead, it was approved to treat patients suffering from nausea and vomiting episodes after undergoing chemotherapy, radiation, or anesthesia.

As these results bear a striking resemblance to the details alleged in complaints of current plaintiffs, they are understandably unsettling. For example, in one Zofran lawsuit, the mother alleges that due to the fact that she took Zofran to treat morning sickness during her first trimester of pregnancy, her baby developed Tetralogy of Fallot (a rare grouping of 4 heart defects) while in utero. The woman notes, “GSK conducted additional animal studies after the launch of Zofran in the U.S. that demonstrated increased risks of harm to fetuses in animals exposed to ondansetron [Zofran’s active ingredient] prenatally.”

Should these concerning allegations be proven to be true, GSK may face increasing public scrutiny. Plaintiffs are anxiously awaiting further results as their consolidated lawsuits progress toward litigation. As they wait, the attorneys of Monheit Law are working to help women who have taken Zofran while pregnant and who have subsequently given birth to children with defects. They want to ensure that these women will be given the opportunity to investigate their legal rights in the matter. Affected women, children, and families could be entitled to substantial compensation attained through legal action. To assist those looking to explore their legal options further, the attorneys of Monheit Law are currently offering complimentary legal consultations for qualified parties.

To request more Zofran birth defect information, or to ask questions, please contact Michael Monheit, Esq. by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60008982

March 30, 2016 – – BloodThinnerHelp.com reports on the details of another Xarelto lawsuit which was filed in the Eastern District of New York involving a woman from Texas who alleges that the blood thinner’s manufacturers, Janssen Pharmaceuticals and Bayer AG, failed to effectively warn the public about potentially dangerous risks linked to the anticoagulant. The plaintiff’s lawsuit was filed under case number 1:14-cv-04524 in a federal court.

Further lawsuit details from court documents report that the plaintiff was prescribed Xarelto by her doctor in order to treat atrial fibrillation, a common heart condition which can place patients at increased risk for strokes. Unfortunately, the woman used the anticoagulant for only 5 months when she suddenly suffered from what she claims was a life-threatening internal bleed. She indicates that the bleed left her with long-term medical problems which will require specialized care and will cause her to incur regular medical bills.

In 2011, the U.S. Food and Drug Administration gave Xarelto approval to be sent to market. Because the drug didn’t require monitoring and adjustments from physicians or any special diets as traditional blood thinners did, it was quite popular, providing users with new freedoms. Today, however, the tides have quickly turned as the drug is the topic of more than 2,800 federally-filed lawsuits and another 600 lawsuits which have formed a mass tort program in Philadelphia, Pennsylvania.

Attorney Joseph Osborne understands how concerning these potential side effect links may be to patients currently using Xarelto. He is working to help anyone who has taken the drug and who has suffered from health problems that they believe the drug caused. Affected patients may be entitled to significant compensation through legal action. Attorney Osborne believes that these individuals deserve the important opportunity to explore their legal rights in full. Those who wish to investigate their rights further are currently offered free legal consultations.

To ask questions regarding Xarelto bleeding lawsuits, or to obtain additional information, please contact Attorney Joseph Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008979

March 30, 2016 – As talcum powder lawsuits (http://www.rxinjuryhelp.com/talcum-powder/lawsuit/) mount in courts around the U.S., Bernstein Liebhard LLP notes that a recent study has suggested that regular use of talc-based products for feminine hygiene purposes may increase a woman’s risk for ovarian cancer. The research, which appeared this past December in the journal Epidemiology, involved 2,041 women with ovarian cancer and 2,100 similar women who did not have the disease, all of whom were surveyed about their talcum powder use. Those who reported that they routinely applied talcum powder to their genitals, underwear, sanitary napkins and tampons had a 33 percent higher risk of ovarian cancer.

“Hundreds of talcum powder lawsuits are now making their way through the courts, all of which allege that regular, genital exposure to Johnson & Johnson talc products contributed to the development of ovarian cancer. This research would certainly seem to support those allegations,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer following years of regular, repeated use of talc-based products for feminine hygiene purposes.

Johnson & Johnson Talcum Powder Litigation
Court records indicate that more than 1,200 talcum powder lawsuits have been filed against Johnson & Johnson over the alleged link between talc-based products and ovarian cancer. A number of these cases have been centralized in a multicounty litigation now underway in New Jersey’s Atlantic County Superior Court. Plaintiffs claim that the company knowingly withheld information and warnings regarding the association between talcum powder and ovarian cancer from the public in order to safeguard profits from its Shower to Shower and Johnson’s Baby Powder products. (In Re: Talc-Based Powder Products, Case No. 300)

On February 22nd, a St. Louis, Missouri jury awarded $72 million to the family of a woman who blamed Johnson & Johnson’s talcum powder products for their mother’s death from ovarian cancer. The verdict marked the first time that a jury ordered the company to pay financial damages in a talcum powder lawsuit. (Cause No. 1422-CC09012-01, Division 10, Missouri Circuit Court, 22nd Judicial District (St. Louis))

Women who were diagnosed with ovarian cancer following the long-term, regular use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal’s “Plaintiffs’ Hot List,” recognizing the top plaintiffs firms in the country. This year’s nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author

GET IN TOUCH
Sandy Liebhard
RX Injury Help
800-511-5092
http://www.rxinjuryhelp.com/

Release ID: 244942

March 30, 2016 – – Cerritos, California – Big 5 Electronics, Southern California’s largest 12-volt distributor and a leader in wholesale car audio, has announced an expansion of their product line. The company has added Crunch, MB Quart, Scosche, Orion, Autopage and Hifonics to the already impressive lineup of car audio brands that they carry.

“Our mission is to elevate the customer service in the car audio distribution industry, bringing you the very best of service and products,” stated Rafael Monroy, Marketing Director for Big 5 Electronics. “These essential brands that are new to our portfolio continue our tradition by populating our product catalog with the most respected and most desired brands in the world today.”

Already boasting a deep and diverse product catalog, Big 5 Electronics now carries some of the most popular wholesale car audio brands in the industry today, including ear-rattling stalwarts such as Kicker, Polk Audio, Metra, PAC, and DEI. The company now offers products — speakers, subwoofers, head units and amps to name a few — from nearly 50 companies.

Already at the forefront of revolutionizing the 12-volt industry, the influx of these top-quality brands continue to invigorate and expand Big 5’s product lines and category offerings.

“We are constantly innovating and growing our business to suit the needs of our customers and carefully pick brands that fulfill those needs,” Monroy continues. “We have been in business for 13 years and continue to grow in a difficult industry and it’s because we continue to evolve. Providing more for our customers is proof of that.”

Big 5 offers customers same-day shipping, next-day delivery, will call, in-house shopping and free technical support in addition to their great selection of wholesale car audio brands.

The announcement of the incoming product lines also coincides with a number of fresh wholesale car audio package deals now offered by Big 5 Electronics. Visit their website at big5electronics.com, or speak to a local representative at (562) 941-4669 or e-mail sales@big5electronics.com for more information.

About Big 5 Electronics

An industry leader among wholesale car audio dealers in the Southern California region, Big 5 Electronics is not only Southern California’s Largest 12 Volt distributor but considered a one stop shop for all retailers. An an authorized car audio dealer, their lengthy lineup featured dozens of wholesale car audio factory authorized brands, including Kicker, AutoPage, and MB Quart, as well as Pioneer, Sony, Kenwood, JVC and more.

fax: (562) 941-4998

e-mail: sales@big5electronics.com

###

Contact Big 5 Electronics:

Rafael Monroy
562-941-4669
marketing@big5electronics.com
13924 Bettencourt St.
Cerritos, CA 90703

ReleaseID: 60008986

March 30, 2016 – – Day Camp Sunshine, a provider of the classic, recreational camp experience in Basking Ridge, NJ, has announced that they have released their 2016 schedule and that online registration is now open. Parents are encouraged to register their children for the preschool, teen and kids summer camp programs as soon as possible, because places are limited.

Todd Haraldsen from Day Camp Sunshine says: “Our summer camp programs are designed to give children the classic camp experience, while fostering Christian character development at the same time. We encourage parents to register their children now. As we strive to maintain a 1:8 staff-camper ratio, spaces are limited.”

Day Camp Sunshine believes in community building, encouraging children to feel truly at home. During a typical day at the kids and teen summer camp programs, children will enjoy music and song, bible lessons, indoor and outdoor activities, snacks and lunch. Additionally, there are opportunities to register for pizza, pool parties, slumber parties and field trips.

While the days are filled with various activities, many of those are electives, which gives camp children the ability to make their own choices as well. “We believe in character building,” adds Todd Haraldsen. “While having a strong focus on Christian values, we encourage children to develop their own personalities, as well as a team working spirit. As such, we offer various electives that kids can choose from, so that they can do things they personally enjoy.”

There are three basic groups and these are the middlers (1st to 3rd graders), seniors (4th to 6th graders) and teens (7th grade and up). These groups rotate between some of the activities, which means children are always able to engage in activities with their peers and relevant to their age. At the end of the week, all children come together and Staff and Camper of the Week are announced, as well as the team winner. This is a culmination of the entire week, where children can share their experiences and discuss what they liked most of their time at the camp and what else they would like to see.

Meanwhile, children who are two and a half years old to kindergarten can join the preschool summer camp programs. The activities are specially designed for this particular age range although these are basically the same as for the regular summer camp programs.

###

Contact Day Camp Sunshine:

Todd Haraldsen
908-647-9624
camp@deaconry.org
3575 Valley Road
Basking Ridge, NJ 07920

ReleaseID: 60008758

March 30, 2016 – – BloodThinnerhelp.com reports on studies which may lend support to current plaintiffs’ arguments in lawsuits filed against Bayer and Janssen Pharmaceuticals regarding potential dangers of the anticoagulant drug Xarelto. Bayer and Janssen (a subdivision of Johnson & Johnson corporation) manufacture the new-generation blood-thinning drug. These studies being discussed appear to highlight a potential increase in the occurrence of stomach and eye bleeds among patients taking Xarelto. This potential risk appeared highest when patients were switching from a traditional blood thinner to the use of Xarelto.

One of the studies was published in an April 2015 issue of BMJ. In this study, researchers evaluated nearly 46,000 medical patients who were taking blood thinners, and noted that they could not rule out as much as a twofold increased risk of the occurrence of stomach bleeds among patients using Xarelto when compared to those taking warfarin, (a traditional blood thinner).

In another study, which was completed by Doctors John C. Hwang and Judy H. Hun, patients who had switched from using traditional blood thinner warfarin to Xarelto appeared to be at increased risk for suffering from vitreous hemorrhages or eye bleeds. In a vitreous hemorrhage, the bleed is located between the lens and retina of the eye. The doctors noted this occurrence among patients at their practice, which spurred them to further study the possible link.

Their findings were published in the June 2015 issue of Jama Ophthalmology, and noted that patients were at increased risk for these bleeds specifically while weaning off of warfarin and transferring to the use of Xarelto. They noted, “In all cases, an acute vitreous hemorrhage occurred shortly after rivaroxaban (Xarelto) treatment was initiated.”

Each of these studies seem to lend support to arguments against the drug currently made by Xarelto lawsuit plaintiffs from across the United States. At this time, complaints filed regarding the drug are in the thousands. Over 2,800 of these lawsuit filings were transferred and consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL number 2592, while more than 600 others have been consolidated to form a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania.

Attorney Joseph Osborne understands how scary these allegations may be for patients currently using Xarelto, and is working to ensure that anyone who used Xarelto and suffered from complications that they believe were caused by their use of the drug will be given the opportunity to fully investigate their legal rights. Affected patients may be eligible for significant compensation gained through legal action. Those looking to explore their legal options more completely are being offered free Xarelto consultations at this time.

To ask questions regarding Xarelto lawsuits, or to request more information, please contact Attorney Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008978

March 30, 2016 – –

Los Angeles – Vecaro Lifestyle is proud to announce that they sell the safest hoverboards available on the market today.

Considering the many reports of hoverboards catching fire, and many cities actually banning them, the fact that the hoverboards sold by Vecaro Lifestyle are certified and inspected by the U.S. Customs and Border Protection sets them apart in today’s market.

Mike Bell from Vecaro Lifestyle says: “Many companies had rushed to make hoverboards available by 2015 because of their popularity. We believe it is this rush to get things completed that makes manufacturers cut corners, which is why so many hoverboards have been found to be unsafe. We are proud of the fact that we took our time in developing our product and ensuring that it meets all necessary safety requirements. We’re happy to see that people trust us when they get their boards from us.”

A number of poorly-made hoverboard brands have been known to catch fire and, in some instances, even explode. There has been one reported incident where a hoverboard caught fire when the device was taken out of the box. This incident was well-publicized because it was caught on camera. Other hoverboards have exploded, causing entire properties to catch fire.

Cheap, poorly-made products that have been flooding the market are behind these incidents.

Because of these poor products, hoverboards have been banned from many cities in the United States, the United Kingdom and other countries.

The Consumer Product Safety Commission (CPSC) has called for outlets that sell hoverboards to allow purchasers to return them until such time that their products have been certified as safe. The CPSC has listed a number of features that they feel should be included in order for a hoverboard to be classed as safe.

Vecaro Lifestyle hoverboards meet all of these specifications.

People who are interested in purchasing a hoverboard are encouraged to visit the Vecaro website at vecarolifestyle.com for further information. Full details about the safety standards and tests are available there, as well as information on how this device sets itself apart from others on the market.

About Vecaro Lifestyle

Our Mission at Vecaro is to provide products you need to complement your connected lifestyle. We only sell UL Certified Hoverboards. Rider safety is our priority. Website: http://www.vecarolifestyle.com/

###

Contact Vecaro Lifestyle:

Mike Bell
323-657-7735
business@vecarolifestyle.com

ReleaseID: 60008887